Peptic ulcer disease - Pathophysiology

Peptic Ulcer Disease: Pathophysiology and Classification Introduction: The Balance Between Aggression and Defense Peptic ulcer disease develops when there is an imbalance between aggressive factors that damage the stomach and duodenal lining and the defensive mechanisms that protect it. Think of the gastric mucosa as being under constant assault from acid and enzymes, but normally the stomach has excellent protective systems to keep this in check. When these defenses fail—or when the attack becomes overwhelming—ulcers form. Understanding this fundamental balance is key to comprehending how peptic ulcers develop and why different treatments work. Mechanism of Ulcer Formation An ulcer is defined by its depth: it must extend through the full thickness of the muscularis mucosae (the muscular layer at the base of the mucosal glands) to be classified as a true ulcer. Shallower defects that don't reach this depth are called erosions. This distinction is clinically important because deeper ulcers carry a greater risk of complications like perforation and bleeding. Ulcers form when aggressive factors outweigh defensive mechanisms. The aggressive factors include: Acid and pepsin: Hydrochloric acid and the enzyme pepsin actively break down tissue Helicobacter pylori infection: Causes chronic inflammation NSAID injury: Damages the protective mucosa directly The defensive mechanisms include: Mucus layer: A gel-like protective coating that shields the epithelium Bicarbonate secretion: Neutralizes acid near the mucosal surface Prostaglandins: Hormones that promote mucus and bicarbonate production Mucosal blood flow: Delivers oxygen and nutrients to support epithelial repair Acid-Mediated Mucosal Injury Gastric acid (hydrochloric acid) is produced by parietal cells in the stomach's gastric glands. In normal circumstances, the stomach produces a steady but controlled amount of acid necessary for protein digestion. However, when acid secretion becomes excessive or the mucosal protective barriers weaken, acid can penetrate deeper into the tissue. The problem is intensified by pepsin, a protease enzyme activated only in acidic conditions. Once activated by stomach acid, pepsin begins to digest proteins—including the proteins that make up the mucosa itself. This creates a vicious cycle: acid activates pepsin, pepsin degrades tissue, acid penetrates deeper, and tissue damage accelerates. The mucus layer normally prevents acid from making direct contact with epithelial cells. However, if the mucus layer becomes thin or is disrupted, or if acid production overwhelms the neutralizing capacity of bicarbonate, acid reaches the vulnerable cell layer beneath. This leads to cell death, inflammation, and progressive tissue erosion until an ulcer forms. Inflammation Induced by Helicobacter pylori Helicobacter pylori is a bacterium that colonizes the gastric mucosa and is responsible for the majority of peptic ulcers worldwide (when NSAIDs aren't involved). The pathophysiology of H. pylori-induced ulcers involves several key steps: Colonization and Toxin Production: H. pylori burrows beneath the mucus layer and establishes infection in the gastric epithelium. The bacteria produce powerful cytotoxins (cell-damaging toxins) and other virulence factors that trigger the immune system. Chronic Inflammation: The body recognizes the infection and mounts an inflammatory response. Immune cells release inflammatory mediators like cytokines and chemokines, causing redness, swelling, and infiltration of white blood cells into the mucosa. This inflammation persists chronically—sometimes for years if untreated. Breakdown of Epithelial Integrity: The chronic inflammation damages tight junctions—the protein connections that normally seal the spaces between epithelial cells. When these tight junctions are disrupted, acid leaks through the epithelial barrier and reaches the deeper tissue layers. Additionally, inflammatory cytokines directly damage epithelial cells and impair their ability to secrete protective mucus and bicarbonate. Progressive Ulceration: As the barrier fails and inflammation continues, the tissue damage progressively deepens until the muscularis mucosae is breached, forming a true ulcer. Non-steroidal Anti-inflammatory Drug Mechanism NSAIDs (such as ibuprofen, naproxen, and aspirin) are among the most common causes of peptic ulcers, accounting for about 20% of cases. Their mechanism of injury is distinct from H. pylori and involves suppression of protective mechanisms rather than direct tissue damage. Inhibition of Cyclooxygenase: NSAIDs work by blocking enzymes called cyclooxygenases (COX-1 and COX-2), which normally produce protective chemicals called prostaglandins. In the stomach, prostaglandins are crucial—they stimulate the secretion of both mucus and bicarbonate, and they promote blood flow to the mucosa. Weakened Mucosal Defense: When NSAID use reduces prostaglandin production, several protective mechanisms fail simultaneously: Mucus secretion decreases, thinning the protective layer Bicarbonate secretion decreases, reducing acid neutralization Mucosal blood flow diminishes, impairing the epithelium's ability to repair itself and resist damage Direct Mucosal Injury: NSAIDs can also directly damage the epithelial cells, particularly in the setting of reduced prostaglandins. They may impair the epithelium's barrier function and increase cell death. The result is a mucosa that is simultaneously more exposed to acid and less able to defend itself or repair damage. This is why long-term NSAID use, particularly in older patients, significantly increases ulcer risk. Healing and Relapse Determinants Understanding what determines successful ulcer healing is clinically important—it explains why some patients relapse while others do not. Requirements for Healing: For H. pylori-associated ulcers, eradication of the infection is essential for healing. This is typically achieved through combination therapy with antibiotics and acid-suppressing medications. Simply reducing acid without eliminating the bacteria usually leads to ulcer recurrence. For NSAID-associated ulcers, cessation of the offending drug is the most critical factor. If a patient continues taking NSAIDs while being treated for an ulcer, healing is severely impaired. Once the NSAID is stopped and acid is suppressed, the mucosal barrier can regenerate. Factors Predicting Relapse: Even after initial healing, ulcers may recur if the underlying problem is not addressed: Continued H. pylori infection (if eradication therapy fails) Resumption of NSAID use without adequate protective therapy Smoking: Impairs mucosal blood flow and healing processes Continued acid hypersecretion: In rare cases of Zollinger-Ellison syndrome, where the stomach produces excessive acid due to a gastrin-secreting tumor Poor medication adherence: Patients who skip doses of acid-suppressing drugs or antibiotics are more likely to relapse Psychological stress and poor sleep: These may increase acid secretion and impair healing The key lesson is that treating an ulcer requires addressing the underlying cause, not just suppressing acid. An ulcer may heal temporarily with acid suppression alone, but without eliminating H. pylori or stopping NSAIDs, relapse is likely.